Apple Podcasts 
Spotify 
YouTube 
RSS Feed Be a Guest on Global Trial Accelerators™
Building or running first-in-human trials? Share what you've learned. Participation is free, and the conversation takes about 30 minutes, recorded online.
Global Trial Accelerators™
Accelerate Your Path from First-in-Human to Exit Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech, Biotech/Biopharma, and Radiopharma, focused on first-in-human (FIH) and early feasibility studies. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials, serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who have compressed timelines, reduced costs, and generated the clinical evidence investors demand by leveraging the Americas' clinical research infrastructure, from Canada to Argentina. What You'll Learn: - Regulatory pathways across Latin America (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay, and more) - Why ethics approval in 4–8 weeks (vs. 6–12 months in the US/EU) changes the game for startups - Strategies to generate FIH data that unlocks your next funding round or acquisition - The Innovation Runway: from prototype to clinical milestones before capital runs out - Lessons from more than 130 episodes with leaders from seed-stage startups to Fortune 500 MedTech companies - Decentralized trials, AI-driven recruitment, and post-trial commercialization Subscribe to unlock your shortcut from first-in-human to exit. Brought to you by bioaccess®, an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
Reach 32,000+ LinkedIn followers through bioaccess® CEO Julio Martinez-Clark
The clinical trials podcast for healthcare startups: your roadmap from first-in-human to exit.
Many healthcare startups run out of capital before they generate the clinical data investors need. Global Trial Accelerators™ is the clinical trials podcast from bioaccess®, a CRO built exclusively for first-in-human (FIH) trials. Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), produced by bioaccess®, and founded by Co-Founder & CEO Julio G. Martinez-Clark.
The Geography Decision
The Geography Decision: where should you run your first-in-human study?
The single highest-leverage decision a MedTech, Biopharma, or Radiopharma startup makes is where to run its first-in-human trial. The U.S. offers the most direct FDA pathway; Latin America offers streamlined ethics approvals, treatment-naïve patient populations, and lower operational costs — with data that supports FDA submissions. Global Trial Accelerators™ exists to help founders make that decision with real evidence: conversations with the founders, regulators, and operators who have run FIH trials on both sides of the equator.
Many healthcare startups run out of capital before they generate the clinical data investors need. Global Trial Accelerators™ is the clinical trials podcast from bioaccess® — a CRO purpose-built exclusively for first-in-human (FIH) trials — built to help you solve that problem faster, smarter, and at lower cost.
Every episode delivers practical strategies from startup founders, CRO executives, regulatory experts, and healthcare investors. Topics include regulatory pathways across Latin America, ethics approval timelines (4–8 weeks vs. 6–12 months in US/EU), FIH trial design for MedTech, Biopharma, and Radiopharma, patient recruitment strategies with treatment-naïve cohorts, and how to generate the clinical milestones that unlock funding rounds and strategic acquisitions.
This podcast is designed for MedTech, Biopharma, and Radiopharma startup founders, regulatory affairs professionals, clinical operations managers, and healthcare investors looking for a competitive edge. Whether you’re preparing for your first FIH trial, a mid-stage company seeking faster clinical pathways, or an investor evaluating clinical-stage opportunities, Global Trial Accelerators™ gives you the insider knowledge you need to move faster and make smarter decisions.
Can clinical trials in Latin America really be faster and more affordable?
Yes. Many countries in Latin America offer streamlined ethics committee approvals that can be completed in 4 to 8 weeks compared to 6–12 months in the US or EU. Combined with lower operational costs, startups can reduce overall trial budgets while maintaining full FDA and EMA compliance.
What types of clinical trials does this podcast cover?
The podcast focuses on first-in-human clinical trials across MedTech (medical devices, diagnostics, digital health), Biopharma (novel therapeutics, biologics, biosimilars), and Radiopharma (radiopharmaceuticals, nuclear medicine). We also explore decentralized trials, AI-driven diagnostics, and theranostics.
Who are the hosts of Global Trial Accelerators™?
The podcast is hosted by Jesús E. Moreno, Business Development Director at bioaccess®, and produced by bioaccess®, founded by Co-Founder & CEO Julio G. Martinez-Clark.
Recent Episodes
Sept. 24, 2026
Benjamin Holmes, Chief Executive Officer at Nanochon
Dr. Ben Holmes: 3D Printing, MedTech, and the Future of Joint Repair In this episode, we speak with Dr. Ben Holmes, CEO and Co-Founder of Nanochon, a medical technology company developing Chondrograft™, a 3D-printed synthetic implant designed to repair damaged cartilage and restore joint function for patients who are not yet candidates for knee replacement. Dr. Holmes holds a Ph.D. in Biomedical Engineering from The George Washington University and a B.S. in Mechanical and Aerospace Engineer…
Sept. 17, 2026
Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
In this episode, we are joined by Allison Komiyama, Founder of Bluestocking Health, for a conversation about medical devices, regulatory strategy, clinical evidence, and the journey of bringing innovative medical technologies to market.
Allison has spent most of her career helping medical device companies navigate the regulatory process and successfully bring their technologies to market. Over the past seventeen years, she has been involved in hundreds of FDA pre-submissions and prem…
Sept. 10, 2026
Daniel Zequeto, Founder & CEO at ODC Life Sciences
In this episode, we speak with Daniel Zequeto, founder of ODC Life Sciences, about the challenges and opportunities of conducting clinical development across Brazil and Latin America.
With more than 20 years of experience as a commercial and clinical leader at Abbott, Hospira, Shire, and Alexion, Daniel has worked on both sides of the equation and witnessed firsthand the challenges sponsors face when entering LATAM without the right local infrastructure.
Daniel shares his per…
Sept. 3, 2026
Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
In this episode, we speak with Dr. Satabhisa Mukhopadhyay, Co-Founder and Chief Scientific Officer of 4D Path and co-inventor of its QPOR™ technology.
Dr. Mukhopadhyay discusses her journey from theoretical physics and applied mathematics to cancer systems biology, bioinformatics, and AI/ML. We explore how physics-informed algorithms and computational approaches can transform complex biological data into actionable insights for personalized cancer treatment.
She also shares i…
Aug. 27, 2026
Deborah Morley, Director CV Strategy and Delivery at RQM+
In this episode, we speak with Deborah Morley, an experienced leader in cardiovascular innovation, clinical research, and medical device development. Her career spans academia and industry, with extensive expertise in regulatory strategy and Class III implantable cardiovascular devices, including LVADs and cardiac contractility modulation systems. She currently serves as Director, Cardiovascular Strategy and Delivery and Co-Leader of the Cardiovascular Center of Excellence at RQM+.
Recent Blog Posts
Oct. 8, 2026
What Trial Teams Miss When Science and Operations Work Separately
A useful clinical strategy is not just scientifically sound. It also has to survive contact with real patients, real sites, real timelines, and real failures. In their conversation with Jesús E. Moreno on Global Trial Accelerators, Joseph Grieco, th…
Oct. 8, 2026
Why Better Data Curation Can Shorten Biomedical R&D
In this Global Trial Accelerators episode, Jesús E. Moreno speaks with Pablo Yarza, founder of BIOINFILE, about a problem that sits underneath nearly every biomedical program: teams cannot move faster than the data they can actually trust.
That sou…
That sou…
About the Hosts
Jesús E. Moreno
Host · Business Development Director, bioaccess®
Jesús E. Moreno is a business development director who provides efficient and reliable clinical research services across the Americas. With a passion for driving innovation in the healthcare sector, Jesús leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesús profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesús is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesús possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesús has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.
Julio G. Martinez-Clark
Founder · CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America as a global leader in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.